A bill to amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs, medical devices, generic drugs, and biosimilar biological products, and for other purposes.
STATUS
Introduced
Last Action on 07/13/2022: [] Placed on Senate Legislative Calendar under General Orders. Calendar No. 444.